Dolby Laboratories (DLB) 49.46 $DLB Dolby Laboratories

New Post Public Reply Private Reply Replies (0) Message Board

Sep 6, 2016 at 11:09 AM

Dolby Laboratories (DLB) 49.46 $DLB

Dolby Laboratories Up 39.0% Since SmarTrend Uptrend Call (DLB)
Comtex SmarTrend(R) - Thu Sep 01, 12:52PM CDT
SmarTrend identified an Uptrend for Dolby Laboratories (NYSE

LB) on January 28th, 2016 at $35.03. In approximately 7 months, Dolby Laboratories has returned 38.97% as of today's recent price of $48.67.
DLB: 49.46 (-0.19)

Uptrend Call Working As Dolby Laboratories Stock Rises 43.2% (DLB)
Comtex SmarTrend(R) - Thu Aug 25, 12:28AM CDT
SmarTrend identified an Uptrend for Dolby Laboratories (NYSE

LB) on January 28th, 2016 at $35.03. In approximately 7 months, Dolby Laboratories has returned 43.18% as of today's recent price of $50.15.
DLB: 49.46 (-0.19)

Can Dolby Continue to Ride on Dolby Cinema's Strength?
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 3:37PM CDT
On Aug 23, we issued an updated research report on Dolby Laboratories, Inc. (DLB).
NFLX: 99.09 (+1.71), DLB: 49.46 (-0.19), AMZN: 780.21 (+7.77), AAPL: 107.74 (+0.01)

Dolby Laboratories Up 42.4% Since SmarTrend Uptrend Call (DLB)
Comtex SmarTrend(R) - Wed Aug 10, 12:23AM CDT
SmarTrend identified an Uptrend for Dolby Laboratories (NYSE

LB) on January 28th, 2016 at $35.03. In approximately 6 months, Dolby Laboratories has returned 42.36% as of today's recent price of $49.86.
DLB: 49.46 (-0.19)

AMC Theatres and Dolby to Accelerate Deployment to 100 Dolby Cinema at AMC Sites by End of 2017
BusinessWire - Mon Aug 08, 12:01PM CDT
In response to impressive guest reaction and the overwhelming success of Dolby Cinema at AMC in its first full year, Dolby Laboratories, Inc. (NYSE: DLB) and AMC Theatres (NYSE: AMC) today announced plans to accelerate Dolby Cinema(TM) at AMC installations to 100 operational sites by the end of 2017, seven years ahead of the originally announced schedule. The original agreement, reached in 2015, was for 100 auditoriums over a 10-year deployment.
DLB: 49.46 (-0.19), AMC: 30.41 (-0.09)

Dolby Laboratories and Littlstar Announce Next-Generation Linear VR Experiences in Dolby Atmos on Littlstar Service
BusinessWire - Thu Aug 04, 8:00AM CDT
Dolby Laboratories, Inc. (NYSE

LB) and Littlstar, a premier global network dedicated to immersive virtual reality (VR) and 360-degree video, today announced that Dolby Atmos(R) audio is expected to be available through the Littlstar(TM) VR application in the Oculus(R) store, SteamVR(TM), Apple(R) App Store(R), and Google Play(TM) store this fall.
DLB: 49.46 (-0.19)

Uptrend Call Working As Dolby Laboratories Stock Rises 39.8% (DLB)
Comtex SmarTrend(R) - Tue Aug 02, 12:59PM CDT
SmarTrend identified an Uptrend for Dolby Laboratories (NYSE

LB) on January 28th, 2016 at $35.03. In approximately 6 months, Dolby Laboratories has returned 39.81% as of today's recent price of $48.97.
DLB: 49.46 (-0.19)

Clarification: Earns-Dolby Laboratories story
AP - Thu Jul 28, 3:29PM CDT
SAN FRANCISCO (AP) — In a story July 27 about Dolby Laboratories Inc.'s earnings, The Associated Press reported that Dolby is a maker of audio equipment. The company creates and licenses audio, video, and voice technologies.
DLB: 49.46 (-0.19)

Dolby Laboratories (DLB) Earnings & Revenues Beat in Q3
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 8:52AM CDT
Dolby Laboratories, Inc. (DLB) reported third-quarter fiscal 2016 adjusted earnings of 65 cents per share, comfortably beating the Zacks Consensus Estimate of 51 cents by 27.4%.
DLB: 49.46 (-0.19), ISLE: 17.35 (+0.05), ELY: 11.56 (-0.04), CRI: 93.34 (-1.78)

Dolby Laboratories Reports Third Quarter Fiscal 2016 Financial Results
BusinessWire - Wed Jul 27, 3:15PM CDT
Dolby Laboratories, Inc. (NYSE

LB) today announced the Company's financial results for the third quarter (Q3) of fiscal year 2016. For the third quarter, Dolby reported total revenue of $277.6 million, compared to $231.7 million for the third quarter of fiscal year 2015.
DLB: 49.46 (-0.19)

GoPro (GPRO) Growth Plans on Track: Rebound in Cards?
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 7:55AM CDT
Wearable and action camera maker GoPro, Inc. (GPRO) is forging ahead with its product endorsement and growth initiatives.
GPRO: 14.48 (+0.35), DLB: 49.46 (-0.19), F: 12.52 (+0.02), MSFT: 57.40 (-0.27)

Photo of Representatives From Dolby Cinema at Wanda Cinemas Opening Event Available on Business Wire's Website and the Associated Press Photo Network
BusinessWire - Thu Jun 23, 11:23PM CDT
On Thursday, June 23, 2016, Dolby Laboratories and Wanda Cinema Line Corporation announced that Dolby Cinema is now available for the first time in Asia at Wanda Cinemas in Dalian, Changchun, Chongqing, and Jinan with plans to expand the number of operating Dolby Cinemas in China to 100 within five years. Pictured at the Dolby Cinema opening event in Dalian (from left to right): Dolby Laboratories Senior Vice President, Dolby Cinema Frank Bryant; Dolby Laboratories Senior Vice President, Cinema Business Group Doug Darrow; Dolby Laboratories President and Chief Executive Officer Kevin Yeaman; Wanda Cinema Line Corporation President and Board Director John Zeng; Wanda Cinema Line Corporation Executive Vice President William Que; CapitaLand Mall Asia Deputy Regional General Manager of Northeast China Region Liu Kai.
DLB: 49.46 (-0.19)

Dolby Cinema Now Available in Asia Through Wanda Cinema Line
BusinessWire - Thu Jun 23, 1:00AM CDT
Wanda Cinema Line Corporation Ltd. and Dolby Laboratories, Inc. (NYSE

LB) today announced the first theatres with Dolby Cinema(TM) in Asia at Wanda cinemas in Dalian, Changchun, Chongqing, and Jinan. Dolby Cinema, featuring Dolby Vision(TM) and Dolby Atmos(R), is a premium cinema offering for exhibitors and moviegoers that combines spectacular image and sound technologies with inspired design to make every visit a completely captivating cinematic event.
DLB: 49.46 (-0.19)

Sony Bets Big on E3: String of Launches for PS4, PS4VR
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 11:06PM CDT
It seems Sony Corporation's (SNE) line of game launches at Electronic Entertainment Expo (E3), a video game conference being held at Los Angeles, will create ripples across the gaming cosmos for quite some time.
DLB: 49.46 (-0.19), FB: 127.69 (+1.18), SNE: 33.26 (+0.62), MSFT: 57.40 (-0.27)

Sony's PS4 Neo Launch Plans Fail to Impress, Stock Down
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 8:09AM CDT
It took Sony Corporation (SNE) a little less than three years to come up with the superior twin of its star product -- PlayStation 4 ("PS4"

video game console -- putting speculations to rest.
DLB: 49.46 (-0.19), SNE: 33.26 (+0.62), MSFT: 57.40 (-0.27)

36.5% Return Seen to Date on SmarTrend Dolby Laboratories Call (DLB)
Comtex SmarTrend(R) - Wed Jun 08, 1:13PM CDT
SmarTrend identified an Uptrend for Dolby Laboratories (NYSE

LB) on January 28th, 2016 at $35.03. In approximately 4 months, Dolby Laboratories has returned 36.55% as of today's recent price of $47.83.
DLB: 49.46 (-0.19)

Dolby Laboratories President and CEO Kevin Yeaman to Present at the 36th Annual William Blair Growth Stock Conference
BusinessWire - Tue Jun 07, 8:00AM CDT
Dolby Laboratories, Inc. (NYSE

LB) today announced that Kevin Yeaman, President and CEO, Dolby Laboratories, will present at the 36th Annual William Blair Growth Stock Conference in Chicago, Illinois, on Wednesday, June 15, 2016, at 11:20 a.m. CDT.
DLB: 49.46 (-0.19)

Bear of the Day: Sony (SNE)
David Bartosiak - ZACKS - Fri Jun 03, 8:01AM CDT
Bear of the Day: Sony (SNE)
DLB: 49.46 (-0.19), GPRO: 14.48 (+0.35), SNE: 33.26 (+0.62)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Layne's Chicken Fingers Expands with Brownsville Opening

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

LaserAway Expands to 244 Clinics Over 20 Years

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

HiTHIUM Joins Cambridge to Boost Global Energy Storage

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...